Economy

Array BioPharma Inc. (ARRY) Shares Sold by TIAA CREF Investment Management LLC

Array BioPharma Inc. (ARRY) Shares Sold by TIAA CREF Investment Management LLC”

Out of the analyst recommendations 3 rate Array Biopharma Inc (NASDAQ:ARRY) stock a Buy, 5 rate the stock Outperform, 1 rate Hold, 0 rate Underperform and 0 recommend a Sell.

ARRY has been the topic of several research analyst reports. Nisa Investment Advisors LLC increased its position in Array BioPharma by 0.3% in the second quarter. BidaskClub lowered Array BioPharma from a "sell" rating to a "strong sell" rating in a research report on Wednesday, July 12th.

Array BioPharma Inc. (ARRY) has an annual dividend of $0, while its annual dividend yield is 0%. The company now has an average rating of "Hold" and a consensus target price of $11.54. United Services Automobile Association increased its position in shares of Array BioPharma by 96.8% in the first quarter. The company had revenue of $33.28 million during the quarter, compared to analyst estimates of $38.28 million.

Insider Trades for Array BioPharma Inc. show that the latest trade was made on 31 Mar 2017 where Robbins (Andrew R.), the Chief Operating Officer completed a transaction type "Buy" in which 9843 shares were traded at a price of $0.

TRADEMARK VIOLATION WARNING: "Array BioPharma Inc".

A number of institutional investors have recently added to or reduced their stakes in ARRY. Institutional investors own 98.01% of the company's stock. The company has market cap of $227.03 million.

Shares of Array Biopharma Inc (NASDAQ:ARRY) now have an Average Brokerage Recommendation of 1.22, number of Recs in ABR is 9 while industry rank of the company by ABR is out of 265.

The counter witnessed a trading volume of 3.73 million shares versus an average volume of 3.46 million shares during last trading session. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal. Canada Pension Plan Investment Board acquired a new position in shares of Array BioPharma during the first quarter valued at approximately $8,497,000. Quantbot Technology Limited Partnership holds 0.01% in Array Biopharma Inc (NASDAQ:ARRY) or 13,100 shares. After $0.04 actual EPS reported by La Quinta Holdings Inc for the previous quarter, Wall Street now forecasts 250.00% EPS growth. J P Morgan Chase & Co upgraded shares of Array BioPharma from a "neutral" rating to an "overweight" rating and upped their price objective for the stock from $9.00 to $10.00 in a report on Wednesday, May 3rd.

Array BioPharma Inc. (ARRY) has 173.7 Million shares outstanding and 170.5 Million shares were floated in market.

Analysts expect Array Biopharma Inc (NASDAQ:ARRY) to report $-0.21 EPS on August, 3.They anticipate $0.04 EPS change or 23.53% from last quarter's $-0.17 EPS. Moreover, Cormorant Asset Management Limited Com has 1.36% invested in Array Biopharma Inc (NASDAQ:ARRY). The stock's current distance from 20-Day Simple Moving Average (SMA20) is -10.41% where SMA50 and SMA200 are -8.76% and -14.23% respectively. The Iguana Healthcare Management Llc holds 100,000 shares with $879,000 value, down from 200,000 last quarter. Currently, the stock has a 1 Year Price Target of $12.33. The business's revenue for the quarter was down 22.7% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.16) earnings per share. California-based Schwab Charles Investment Mgmt has invested 0.01% in Array Biopharma Inc (NASDAQ:ARRY). The brokerage presently has a "buy" rating on the biopharmaceutical company's stock. Next Group Inc stated it has 0% in Array Biopharma Inc (NASDAQ:ARRY).

The Female Health Company has a consensus outperform rating from 1 Wall Street analysts, and the number of shares now sold short amount to at least 1.05% of shares outstanding. If you are reading this news story on another publication, it was illegally copied and reposted in violation of USA and global copyright and trademark law.

Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.



Like this

Latest


29 July 2017
Apple discontinues older iPod models Shuffle, Nano
Apple said the new iPod line will consist of two models of the iPod Touch ranging form $199 to $299 depending on storage capacity. The nano received a touch screen and Bluetooth support in a 2012 update , and the shuffle received a total redesign in 2010.

29 July 2017
Fox News host floats Sessions to replace Kelly at Homeland Security
Bush. "As the secretary of Homeland Security", Perino said Friday on Fox News' "The Five". A White House spokesman referred questions about Sessions to the Department of Justice.

29 July 2017
Seebohm makes a splash with first gold
Seebohm denied that there was pressure to grab an elusive gold but hoped her breakthrough win would inspire Australia on the final day.

29 July 2017
'Harry Potter' author JK Rowling caught spreading awful lie about Trump
During a speech on health care Friday morning, President Donald Trump was seen completely snubbing a disabled child's handshake. Rowling has spoken out to slam President Trump after he appeared to ignore a boy in a wheelchair's attempt to shake his hand.

29 July 2017
US Navy Fires Warning Shots near Iranian Vessels Again
In January, the USS Mahan fired shots toward Iranian fast-attack boats as they neared the destroyer in the Strait of Hormuz. The Guards denied approaching the US ship on that occasion and said it was the American vessel that had been at fault.

29 July 2017
Russian Federation was against me in 2016 - Donald Trump
Steele was hired by the company Fusion GPS to create the dossier during the 2016 presidential campaign. Fusion GPS is relevant to the Russian Federation investigation for two reasons.

29 July 2017
Geoffrey Kondogbia own goal
Courtois saved to his left, but Inter reacted fastest to the rebound as Jovetic cleaned up. An attempted back pass from Kondogbia looped over his own goalie to halve our deficit.

29 July 2017
Di Grassi on pole, title rival Buemi penalised
Oliver Turvey finished ninth for NextEV ahead of Venturi's Tom Dillmann, while Loic Duval and Daniel Abt were 11th and 12th. He used his second auto for qualifying, but drivers need both vehicles to take part in the race.

29 July 2017
Weather: Mix of sunshine and showers for today
Umbrellas are advised for Sunday, with heavier showers extending country-wide, posing a "risk of thundery downpours". Highest temperatures will be between 15 to 19 degrees in moderate to fresh and occasionally gusty southwest winds.

29 July 2017
2 dead, 2 recovering after Salisbury shooting
At 2:13 a.m., dispatchers started receiving calls about multiple shots being fired at the 100 block of West Fisher Street. Two men are dead and three others are recovering from their injuries after a Rowan County shooting Saturday morning.



Recommended